Alesco Advisors’s AbbVie ABBV Stock Holding History

Alesco Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$872K	Buy	3,465 +406	+13%	+$87.3K	0.02%	123
2026 Q1	$665K	Sell	3,059 -6	-0.2%	-$1.33K	0.02%	149
2025 Q4	$700K	Sell	3,065 -555	-15%	-$126K	0.02%	123
2025 Q3	$838K	Buy	3,620 +956	+36%	+$195K	0.02%	107
2025 Q2	$494K	Buy	2,664 +992	+59%	+$184K	0.01%	134
2025 Q1	$350K	Buy	1,672 +31	+2%	+$6.03K	0.01%	147
2024 Q4	$292K	Buy	1,641 +213	+15%	+$39.2K	0.01%	156
2024 Q3	$282K	Sell	1,428 -29	-2%	-$5.41K	0.01%	152
2024 Q2	$250K	Buy	1,457 +195	+15%	+$32.3K	0.01%	161
2024 Q1	$230K	Buy	+1,262	New	+$217K	0.01%	170
2023 Q2	–	Sell	-1,404	Closed	-$224K	–	165
2023 Q1	$224K	Buy	1,404 +152	+12%	+$23.2K	0.01%	156
2022 Q4	$202K	Buy	+1,252	New	+$192K	0.01%	163

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Alesco Advisors's ABBV Position: Q2 2026 in Review

Alesco Advisors increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $87.3K and bringing the position to 3,465 shares worth $872K. The position accounts for 0.02% of the portfolio, ranked #123.

Alesco Advisors first reported a position in ABBV in Q4 2022 and has held it in 12 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Alesco Advisors held 3,465 shares of AbbVie worth $872K as of Q2 2026.
Alesco Advisors bought 406 AbbVie shares in Q2 2026, an estimated $87.3K.
AbbVie made up 0.02% of Alesco Advisors's portfolio in Q2 2026, its #123 holding.
Alesco Advisors first reported a position in AbbVie in Q4 2022 and has held it in 12 quarters since.
2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alesco Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.